{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:48:58Z","timestamp":1788194938563,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R21HS028485"],"award-info":[{"award-number":["R21HS028485"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R21HS028485"],"award-info":[{"award-number":["R21HS028485"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R21HS028485"],"award-info":[{"award-number":["R21HS028485"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R21HS028485"],"award-info":[{"award-number":["R21HS028485"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R21HS028485"],"award-info":[{"award-number":["R21HS028485"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Identifying patterns within ICU medication regimens may help artificial intelligence algorithms to better predict patient outcomes; however, machine learning methods incorporating medications require further development, including standardized terminology. The Common Data Model for Intensive Care Unit (ICU) Medications (CDM-ICURx) may provide important infrastructure to clinicians and researchers to support artificial intelligence analysis of medication-related outcomes and healthcare costs. Using an unsupervised cluster analysis approach in combination with this common data model, the objective of this evaluation was to identify novel patterns of medication clusters (termed \u2018pharmacophenotypes\u2019) correlated with ICU adverse events (e.g., fluid overload) and patient-centered outcomes (e.g., mortality).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This was a retrospective, observational cohort study of 991 critically ill adults. To identify pharmacophenotypes, unsupervised machine learning analysis with automated feature learning using restricted Boltzmann machine and hierarchical clustering was performed on the medication administration records of each patient during the first 24\u00a0h of their ICU stay. Hierarchical agglomerative clustering was applied to identify unique patient clusters. Distributions of medications across pharmacophenotypes were described, and differences among patient clusters were compared using signed rank tests and Fisher's exact tests, as appropriate.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 30,550 medication orders for the 991 patients were analyzed; five unique patient clusters and six unique pharmacophenotypes were identified. For patient outcomes, compared to patients in Clusters 1 and 3, patients in Cluster 5 had a significantly shorter duration of mechanical ventilation and ICU length of stay (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05); for medications, Cluster 5 had a higher distribution of Pharmacophenotype 1 and a smaller distribution of Pharmacophenotype 2, compared to Clusters 1 and 3. For outcomes, patients in Cluster 2, despite having the highest severity of illness and greatest medication regimen complexity, had the lowest overall mortality; for medications, Cluster 2 also had a comparably higher distribution of Pharmacophenotype 6.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The results of this evaluation suggest that patterns among patient clusters and medication regimens may be observed using empiric methods of unsupervised machine learning in combination with a common data model. These results have potential because while phenotyping approaches have been used to classify heterogenous syndromes in critical illness to better define treatment response, the entire medication administration record has not been incorporated in those analyses. Applying knowledge of these patterns at the bedside requires further algorithm development and clinical application but may have the future potential to be leveraged in guiding medication-related decision making to improve treatment outcomes.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13054-023-04437-2","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T14:52:57Z","timestamp":1683039177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Pharmacophenotype identification of intensive care unit medications using unsupervised cluster analysis of the ICURx common data model"],"prefix":"10.1186","volume":"27","author":[{"given":"Andrea","family":"Sikora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Rafiei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milad Ghiasi","family":"Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli","family":"Keats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Devlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishikesan","family":"Kamaleswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"MRC-ICU Investigator Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,2]]},"reference":[{"key":"4437_CR1","doi-asserted-by":"publisher","unstructured":"Newsome AS, Murray B, Smith SE, Brothers T, Al-Mamun MA, Chase AM, Rowe S, Buckley MS, Murphy DJ, Devlin JW. Optimization of critical care pharmacy clinical services: A gap analysis approach. Am J Health Syst Pharm. 2021;78(22):2077\u201385. https:\/\/doi.org\/10.1093\/ajhp\/zxab237.","DOI":"10.1093\/ajhp\/zxab237"},{"key":"4437_CR2","doi-asserted-by":"publisher","first-page":"e813","DOI":"10.1097\/CCM.0000000000004437","volume":"48","author":"I Lat","year":"2020","unstructured":"Lat I, et al. Position paper on critical care pharmacy services: 2020 update. Crit Care Med. 2020;48:e813\u201334.","journal-title":"Crit Care Med"},{"key":"4437_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41572-019-0069-0","volume":"5","author":"MA Matthay","year":"2019","unstructured":"Matthay MA, et al. Acute respiratory distress syndrome. Nat Rev Dis Primers. 2019;5:18.","journal-title":"Nat Rev Dis Primers"},{"key":"4437_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13054-019-2372-2","volume":"23","author":"A Leligdowicz","year":"2019","unstructured":"Leligdowicz A, Matthay MA. Heterogeneity in sepsis: new biological evidence with clinical applications. Crit Care. 2019;23:80.","journal-title":"Crit Care"},{"key":"4437_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1164\/rccm.201512-2544CP","volume":"194","author":"HC Prescott","year":"2016","unstructured":"Prescott HC, Calfee CS, Thompson BT, Angus DC, Liu VX. Toward smarter lumping and smarter splitting: rethinking strategies for sepsis and acute respiratory distress syndrome clinical trial design. Am J Respir Crit Care Med. 2016;194:147\u201355.","journal-title":"Am J Respir Crit Care Med"},{"key":"4437_CR6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S1473-3099(15)70112-X","volume":"15","author":"J Cohen","year":"2015","unstructured":"Cohen J, et al. Sepsis: a roadmap for future research. Lancet Infect Dis. 2015;15:581\u2013614.","journal-title":"Lancet Infect Dis"},{"key":"4437_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12931-020-01588-6","volume":"21","author":"L Su","year":"2020","unstructured":"Su L, et al. Five novel clinical phenotypes for critically ill patients with mechanical ventilation in intensive care units: a retrospective and multi database study. Respir Res. 2020;21:325.","journal-title":"Respir Res"},{"key":"4437_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MCC.0000000000000903","volume":"28","author":"N Alipanah","year":"2022","unstructured":"Alipanah N, Calfee CS. Phenotyping in acute respiratory distress syndrome: state of the art and clinical implications. Curr Opin Crit Care. 2022;28:1\u20138.","journal-title":"Curr Opin Crit Care"},{"key":"4437_CR9","doi-asserted-by":"publisher","unstructured":"Messmer AS, Moser M, Zuercher P, Schefold JC, M\u00fcller M, Pfortmueller CA. Fluid overload phenotypes in critical illness-a machine learning approach. J Clin Med. 2022;11(2):336. https:\/\/doi.org\/10.3390\/jcm11020336.","DOI":"10.3390\/jcm11020336"},{"key":"4437_CR10","doi-asserted-by":"crossref","unstructured":"Yao L, et al. A survey on causal inference. ACM Trans Knowl Discov Data (TKDD). 2021.","DOI":"10.1145\/3444944"},{"key":"4437_CR11","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/CCM.0000000000001571","volume":"44","author":"MM Churpek","year":"2016","unstructured":"Churpek MM, et al. Multicenter comparison of machine learning methods and conventional regression for predicting clinical deterioration on the wards. Crit Care Med. 2016;44:368\u201374.","journal-title":"Crit Care Med"},{"key":"4437_CR12","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1097\/CCM.0000000000003803","volume":"47","author":"JC Ginestra","year":"2019","unstructured":"Ginestra JC, et al. Clinician perception of a machine learning-based early warning system designed to predict severe sepsis and septic shock. Crit Care Med. 2019;47:1477\u201384.","journal-title":"Crit Care Med"},{"key":"4437_CR13","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1097\/CCM.0000000000003123","volume":"46","author":"JL Koyner","year":"2018","unstructured":"Koyner JL, Carey KA, Edelson DP, Churpek MM. The development of a machine learning inpatient acute kidney injury prediction model. Crit Care Med. 2018;46:1070\u20137.","journal-title":"Crit Care Med"},{"key":"4437_CR14","doi-asserted-by":"crossref","unstructured":"Liu R, Greenstein JL, Fackler JC, Bembea MM, Winslow RL Spectral clustering of risk score trajectories stratifies sepsis patients by clinical outcome and interventions received. Elife. 2020; 9.","DOI":"10.7554\/eLife.58142"},{"key":"4437_CR15","doi-asserted-by":"publisher","first-page":"23019","DOI":"10.1038\/s41598-021-02354-4","volume":"11","author":"JR Grunwell","year":"2021","unstructured":"Grunwell JR, et al. Cluster analysis and profiling of airway fluid metabolites in pediatric acute hypoxemic respiratory failure. Sci Rep. 2021;11:23019.","journal-title":"Sci Rep"},{"key":"4437_CR16","doi-asserted-by":"crossref","first-page":"e1196","DOI":"10.1097\/CCM.0000000000005175","volume":"49","author":"AL Holder","year":"2021","unstructured":"Holder AL, Shashikumar SP, Wardi G, Buchman TG, Nemati S. A Locally optimized data-driven tool to predict sepsis-associated vasopressor use in the ICU. Crit Care Med. 2021;49:e1196\u2013205.","journal-title":"Crit Care Med"},{"key":"4437_CR17","doi-asserted-by":"publisher","first-page":"e0257056","DOI":"10.1371\/journal.pone.0257056","volume":"16","author":"L Singhal","year":"2021","unstructured":"Singhal L, et al. eARDS: a multi-center validation of an interpretable machine learning algorithm of early onset Acute Respiratory Distress Syndrome (ARDS) among critically ill adults with COVID-19. PLoS ONE. 2021;16:e0257056.","journal-title":"PLoS ONE"},{"key":"4437_CR18","unstructured":"Practices, I.o.S.M. High Alert Medications (2018)."},{"key":"4437_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13054-017-1653-x","volume":"21","author":"DM Maslove","year":"2017","unstructured":"Maslove DM, Lamontagne F, Marshall JC, Heyland DK. A path to precision in the ICU. Crit Care. 2017;21:79.","journal-title":"Crit Care"},{"key":"4437_CR20","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1097\/CCM.0000000000001722","volume":"44","author":"NA Halpern","year":"2016","unstructured":"Halpern NA, Goldman DA, Tan KS, Pastores SM. Trends in critical care beds and use among population groups and medicare and medicaid beneficiaries in the United States: 2000\u20132010. Crit Care Med. 2016;44:1490\u20139.","journal-title":"Crit Care Med"},{"key":"4437_CR21","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1097\/00003246-199708000-00014","volume":"25","author":"DJ Cullen","year":"1997","unstructured":"Cullen DJ, et al. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med. 1997;25:1289\u201397.","journal-title":"Crit Care Med"},{"key":"4437_CR22","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1093\/ajhp\/zxab237","volume":"78","author":"AS Newsome","year":"2021","unstructured":"Newsome AS, et al. Optimization of critical care pharmacy clinical services: a gap analysis approach. Am J Health Syst Pharm. 2021;78:2077\u201385.","journal-title":"Am J Health Syst Pharm"},{"key":"4437_CR23","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1177\/0885066620956620","volume":"36","author":"D Nguyen","year":"2021","unstructured":"Nguyen D, Ngo B, van Sonnenberg E. AI in the intensive care unit: up-to-date review. J Intensive Care Med. 2021;36:1115\u201323.","journal-title":"J Intensive Care Med"},{"key":"4437_CR24","doi-asserted-by":"publisher","unstructured":"Upadhya V, Sastry PS. Learning gaussian-Bernoulli RBMs using difference of convex functions optimization. IEEE Trans Neural Netw Learn Syst. 2021. https:\/\/doi.org\/10.1109\/TNNLS.2021.3071358. https:\/\/arxiv.org\/abs\/2102.06228.","DOI":"10.1109\/TNNLS.2021.3071358"},{"key":"4437_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-04898-2_455","volume-title":"International encyclopedia of statistical science","author":"I Jolliffe","year":"2014","unstructured":"Jolliffe I. Principal component analysis. In: Lovric M, editor. International encyclopedia of statistical science. Heidelberg: Springer; 2014. https:\/\/doi.org\/10.1007\/978-3-642-04898-2_455."},{"key":"4437_CR26","doi-asserted-by":"publisher","first-page":"S92","DOI":"10.1093\/ajhp\/zxz213","volume":"76","author":"AS Newsome","year":"2019","unstructured":"Newsome AS, Anderson D, Gwynn ME, Waller JL. Characterization of changes in medication complexity using a modified scoring tool. Am J Health Syst Pharm. 2019;76:S92\u20135.","journal-title":"Am J Health Syst Pharm"},{"key":"4437_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/jac5.1146","volume":"3","author":"A Newsome","year":"2020","unstructured":"Newsome A, Smith SE, Olney WJ, et al. Medication regimen complexity is associated with pharmacistinterventions and drug-drug interactions: a use of the novel MRC-ICU scoring tool. J Am Coll Clin Pharm. 2020;3:47\u201356.","journal-title":"J Am Coll Clin Pharm"},{"key":"4437_CR28","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1093\/ajhp\/zxz330","volume":"77","author":"AS Newsome","year":"2020","unstructured":"Newsome AS, Smith SE, Olney WJ, Jones TW. Multicenter validation of a novel medication-regimen complexity scoring tool. Am J Health Syst Pharm. 2020;77:474\u20138.","journal-title":"Am J Health Syst Pharm"},{"key":"4437_CR29","doi-asserted-by":"publisher","DOI":"10.1177\/0897190021999","author":"WJ Olney","year":"2021","unstructured":"Olney WJ, Chase AM, Hannah SA, Smith SE, Newsome AS. Medication regimen complexity score as an indicator of fluid balance in critically Ill patients. J Pharm Pract. 2021. https:\/\/doi.org\/10.1177\/0897190021999.","journal-title":"J Pharm Pract"},{"key":"4437_CR30","doi-asserted-by":"crossref","unstructured":"Smith SE, Shelley R, Newsome AS. Medication regimen complexity vs patient acuity for predicting critical care pharmacist interventions. Am J Health Syst Pharm. 2021.","DOI":"10.1093\/ajhp\/zxab460"},{"issue":"2","key":"4437_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1145\/2897350.2897352","volume":"17","author":"Y Li","year":"2016","unstructured":"Li Y, Gao J, Meng C, Li Q, Su L, Zhao B, Fan W, Han J. A survey on truth discovery. ACM SIGKDD Explor Newsl. 2016;17(2):1\u201316.","journal-title":"ACM SIGKDD Explor Newsl"},{"key":"4437_CR32","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1097\/CCM.0b013e318168ea3e","volume":"36","author":"GA Ospina-Tascon","year":"2008","unstructured":"Ospina-Tascon GA, Buchele GL, Vincent JL. Multicenter, randomized, controlled trials evaluating mortality in intensive care: doomed to fail? Crit Care Med. 2008;36:1311\u201322.","journal-title":"Crit Care Med"},{"key":"4437_CR33","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00134-014-3272-1","volume":"40","author":"AR Tonelli","year":"2014","unstructured":"Tonelli AR, Zein J, Adams J, Ioannidis JP. Effects of interventions on survival in acute respiratory distress syndrome: an umbrella review of 159 published randomized trials and 29 meta-analyses. Intensive Care Med. 2014;40:769\u201387.","journal-title":"Intensive Care Med"},{"key":"4437_CR34","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S2213-2600(18)30279-0","volume":"6","author":"JG Laffey","year":"2018","unstructured":"Laffey JG, Kavanagh BP. Negative trials in critical care: why most research is probably wrong. Lancet Respir Med. 2018;6:659\u201360.","journal-title":"Lancet Respir Med"},{"key":"4437_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41747-020-0145-y","volume":"4","author":"G Di Leo","year":"2020","unstructured":"Di Leo G, Sardanelli F. Statistical significance: p value, 0.05 threshold, and applications to radiomics-reasons for a conservative approach. Eur Radiol Exp. 2020;4:18.","journal-title":"Eur Radiol Exp"},{"key":"4437_CR36","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1089\/sur.2016.021","volume":"17","author":"AJ Lewis","year":"2016","unstructured":"Lewis AJ, Seymour CW, Rosengart MR. Current murine models of sepsis. Surg Infect (Larchmt). 2016;17:385\u201393.","journal-title":"Surg Infect (Larchmt)"},{"key":"4437_CR37","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1177\/0897190019853979","volume":"33","author":"WA Hawkins","year":"2020","unstructured":"Hawkins WA, et al. Fluid stewardship during critical illness: a call to action. J Pharm Pract. 2020;33:863\u201373.","journal-title":"J Pharm Pract"},{"key":"4437_CR38","doi-asserted-by":"publisher","first-page":"558","DOI":"10.2174\/138920021907180709121120","volume":"19","author":"J Huang","year":"2018","unstructured":"Huang J. Drug-induced nephrotoxicity and drug metabolism in renal failure. Curr Drug Metab. 2018;19:558.","journal-title":"Curr Drug Metab"},{"key":"4437_CR39","doi-asserted-by":"publisher","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","volume":"46","author":"JW Devlin","year":"2018","unstructured":"Devlin JW, et al. Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46:e825\u201373.","journal-title":"Crit Care Med"},{"key":"4437_CR40","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/CCM.0000000000003830","volume":"47","author":"H Lee","year":"2019","unstructured":"Lee H, et al. Impact on patient outcomes of pharmacist participation in multidisciplinary critical care teams: a systematic review and meta-analysis. Crit Care Med. 2019;47:1243\u201350.","journal-title":"Crit Care Med"},{"key":"4437_CR41","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S2213-2600(18)30177-2","volume":"6","author":"CS Calfee","year":"2018","unstructured":"Calfee CS, et al. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial. Lancet Respir Med. 2018;6:691\u20138.","journal-title":"Lancet Respir Med"},{"key":"4437_CR42","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1164\/rccm.201603-0645OC","volume":"195","author":"KR Famous","year":"2017","unstructured":"Famous KR, et al. Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am J Respir Crit Care Med. 2017;195:331\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"4437_CR43","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.2019.5791","volume":"321","author":"CW Seymour","year":"2019","unstructured":"Seymour CW, et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA. 2019;321:2003\u201317.","journal-title":"JAMA"},{"key":"4437_CR44","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00134-019-05596-z","volume":"45","author":"G Geri","year":"2019","unstructured":"Geri G, et al. Cardiovascular clusters in septic shock combining clinical and echocardiographic parameters: a post hoc analysis. Intensive Care Med. 2019;45:657\u201367.","journal-title":"Intensive Care Med"},{"key":"4437_CR45","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1177\/1060028020959042","volume":"55","author":"MA Al-Mamun","year":"2021","unstructured":"Al-Mamun MA, Brothers T, Newsome AS. Development of machine learning models to validate a medication regimen complexity scoring tool for critically Ill patients. Ann Pharmacother. 2021;55:421\u20139.","journal-title":"Ann Pharmacother"},{"key":"4437_CR46","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1093\/ajhp\/zxy054","volume":"76","author":"ME Gwynn","year":"2019","unstructured":"Gwynn ME, Poisson MO, Waller JL, Newsome AS. Development and validation of a medication regimen complexity scoring tool for critically ill patients. Am J Health Syst Pharm. 2019;76:S34\u201340.","journal-title":"Am J Health Syst Pharm"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04437-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-023-04437-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04437-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T22:16:12Z","timestamp":1702332972000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-023-04437-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,2]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4437"],"URL":"https:\/\/doi.org\/10.1186\/s13054-023-04437-2","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,2]]},"assertion":[{"value":"13 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The University of Georgia Institutional Review Board reviewed this study and deemed it exempt (PROJECT00002652).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"167"}}